Research
Molecular
Tirzepatide improves β-cell function in T2D patients by reprogramming stressed β cells and restoring β-cell identity through FOXO1-dependent transcriptional reactivation.
Practitioners may consider tirzepatide as a therapeutic option for improving β-cell function in T2D patients.
StrongSupportsmedium confidence
Hence, our study suggested that tirzepatide restores β-cell function in T2D by reprogramming stressed β cells and re-establishing β-cell identity through FOXO1-dependent transcriptional reactivation.
Why this rating
The study involves both animal and human data, indicating strong evidence.
Source
Tirzepatide improves pancreatic β-cell function in mice and patients with type 2 diabetes
Zhehui Li et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2026
DOI 10.64898/2026.02.13.704343
other
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →